These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 32792490)

  • 1. Podocytopathies.
    Kopp JB; Anders HJ; Susztak K; Podestà MA; Remuzzi G; Hildebrandt F; Romagnani P
    Nat Rev Dis Primers; 2020 Aug; 6(1):68. PubMed ID: 32792490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocytopathies.
    Nat Rev Dis Primers; 2020 Aug; 6(1):67. PubMed ID: 32792477
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric nephrotic syndrome: from the simple to the complex.
    Lane JC; Kaskel FJ
    Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The podocyte as a direct target of immunosuppressive agents.
    Schönenberger E; Ehrich JH; Haller H; Schiffer M
    Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
    Barisoni L; Schnaper HW; Kopp JB
    Clin J Am Soc Nephrol; 2007 May; 2(3):529-42. PubMed ID: 17699461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Podocyte Biology.
    Garg P
    Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
    Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
    J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
    Ahn W; Bomback AS
    Am J Kidney Dis; 2020 Jun; 75(6):955-964. PubMed ID: 32331832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the pathogenesis of nephrotic proteinuria.
    Tesar V; Zima T
    Crit Rev Clin Lab Sci; 2008; 45(2):139-220. PubMed ID: 18415815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collapsing glomerulopathy: update.
    Morales E; Alonso M; Gutiérrez E
    Med Clin (Barc); 2019 May; 152(9):361-367. PubMed ID: 30554809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic collapsing glomerulopathy in children: report of two cases].
    Wei RG; Chen SM; Jiang T; Jiang XY; Zeng Y; Mo Y
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):731-3. PubMed ID: 16221337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining diagnostic trajectories in patients with podocytopathies.
    Cirillo L; Lugli G; Raglianti V; Ravaglia F; Buti E; Landini S; Becherucci F
    Clin Kidney J; 2022 Nov; 15(11):2006-2019. PubMed ID: 36325008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
    Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
    Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies.
    Ye Q; Zhou C; Wang D; Fu H; Wang J; Mao J
    Clin Immunol; 2021 Nov; 232():108869. PubMed ID: 34600127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it Time to Re-Evaluate Our Experimental Approach to Studying Diffuse Podocytopathies?
    Watts AJB; Weins A
    J Am Soc Nephrol; 2022 Nov; 33(11):1959-1960. PubMed ID: 36137754
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inherited podocytopathies].
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():327-39. PubMed ID: 20804104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.